David Floyd - 30 May 2025 Form 4 Insider Report for MERIT MEDICAL SYSTEMS INC (MMSI)

Reporting relationship: Director
Issuer ticker: MMSI
Reported as of: 30 May 2025
Net transaction value: -$330,972
SEC form: 4
Accepted by SEC: 03 Jun 2025, 17:44:47 UTC
Prior SEC filing: 19 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Brian G. Lloyd, Attorney-in-Fact

Key filing fact

David Floyd filed Form 4 for MERIT MEDICAL SYSTEMS INC (MMSI) on 03 Jun 2025.

Key facts

This page summarizes David Floyd's Form 4 filing for MERIT MEDICAL SYSTEMS INC (MMSI).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Jun 2025, 17:44.

Change

Previous filing in this sequence was filed on 19 May 2025.
Current net transaction value: -$330,972.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001564203 Primary reporting owner

Floyd David

Relationship: Director
Address: 1600 WEST MERIT PARKWAY, SOUTH JORDAN
Signature: /s/ Brian G. Lloyd, Attorney-in-Fact
Signature date: 03 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MMSI transaction

Common Stock, No Par Value

Sale

Transaction value: $330,972
Shares: -3,515
Change %: -42%
Price: $94.16
Shares after: 4,880
Date: 30 May 2025
Ownership: David K. Floyd Living Trust
Footnotes: F1, F2

MMSI holding

Common Stock, No Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,584
Date: 30 May 2025
Ownership: David & Lisa Floyd Family LP

MMSI holding

Common Stock, No Par Value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 8,602
Date: 30 May 2025
Ownership: Direct

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025

Footnote F2

The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $93.87 to $94.46, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.